Multiple studies have shown that peroxisome proliferator-activated receptors (PPARs, including PPARα, PPARβ and PPARγ), markers of lipid metabolism-related signalling pathways, are activated by FABP5 and are involved in the progression of human cancers. Here, FABP5 is linked to cancer.